Accessibility Menu
LyondellBasell Industries Stock Quote

LyondellBasell Industries (NYSE: LYB)

$45.22
(-0.9%)
-0.40
Price as of October 21, 2025, 3:58 p.m. ET

KEY DATA POINTS

Current Price
$45.21
Daily Change
(-0.9%) $0.40
Day's Range
$45.02 - $45.98
Previous Close
$45.21
Open
$45.65
Beta
0.95
Volume
248
Average Volume
4,978,663
Sector
Market Cap
14.5B
Market Cap / Employee
$45.21M
52wk Range
$44.89 - $89.5
Revenue
-
Gross Margin
0.09%
Dividend Yield
11.99%
EPS
$0.76
CAPs Rating
-
Industry
Chemicals

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

LyondellBasell Industries Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
LYB-45.33%-18.86%-4.09%+398%
S&P+15.06%+95.03%+14.29%+465%

LyondellBasell Industries Company Info

LyondellBasell Industries NV engages in the refinery and production of plastic resins and other chemicals. It operates through the following segments: Olefins and Polyolefins-Americas; Olefins and Polyolefins-Europe, Asia, International; Intermediates and Derivatives; Advanced Polymer Solutions; Refining; and Technology. The Olefins and Polyolefins-Americas segment produces and markets olefins and co-products, polyethylene and polypropylene. The Olefins and Polyolefins-Europe, Asia, International segment also offers olefins and polyolefins. The Intermediates and Derivatives segment includes propylene oxide and its derivatives; oxyfuels and related products; and intermediate chemicals. The Advanced Polymer Solutions segment produces and markets compounding and solutions, such as polypropylene compounds, engineered plastics, masterbatches, colors and powders, engineered composites, and advanced polymers. The Refining segment refines heavy, high-sulfur crude oil and other crude oils of varied types and sources. The Technology segment develops chemical and polyolefin process technologies and manufactures and sells polyolefin catalysts. The company was founded in December 2007 and is headquartered in London, the United Kingdom.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$7.66B-27.4%
Gross Profit$800.00M-41.0%
Gross Margin10.45%-2.4%
Market Cap$18.60B-40.3%
Market Cap / Employee$0.93M0.0%
Employees20K0.0%
Net Income$152.00M-83.5%
EBITDA$662.00M-49.2%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$1.70B-40.5%
Accounts Receivable$3.21B-21.1%
Inventory4.6K-10.0%

Liabilities

Q2 2025YOY Change
Long Term Debt$12.62B1.9%
Short Term Debt$614.00M254.9%

Ratios

Q2 2025YOY Change
Return On Assets0.38%-5.9%
Return On Invested Capital11.68%-2.1%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$188.00M-121.8%
Operating Free Cash Flow$351.00M-74.0%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Earnings14.6017.9321.7775.90463.77%
Price to Book2.321.761.831.53-36.18%
Price to Sales0.770.600.600.53-30.43%
Price to Tangible Book Value2.782.102.211.86-35.85%
Price to Free Cash Flow TTM17.2131.6134.6596.22-
Enterprise Value to EBITDA36.2952.3573.6545.7545.38%
Free Cash Flow Yield5.8%3.2%2.9%1.0%-
Return on Equity16.0%10.7%7.2%1.1%-93.87%
Total Debt$12.62B$12.92B$12.66B$13.23B5.41%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.